Dopamine and glutamate in schizophrenia: biology, symptoms and treatment (2020)
Attributed to:
MICA: Targeting neuro-inflammation in Schizophrenia
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1002/wps.20693
PubMed Identifier: 31922684
Publication URI: http://europepmc.org/abstract/MED/31922684
Type: Journal Article/Review
Parent Publication: World Psychiatry
Issue: 1
ISSN: 1723-8617